202 related articles for article (PubMed ID: 35463384)
1. Sarcopenia and Systemic Inflammation Response Index Predict Response to Systemic Therapy for Hepatocellular Carcinoma and Are Associated With Immune Cells.
Zhao M; Duan X; Han X; Wang J; Han G; Mi L; Shi J; Li N; Yin X; Hou J; Yin F
Front Oncol; 2022; 12():854096. PubMed ID: 35463384
[TBL] [Abstract][Full Text] [Related]
2. Prognosis of hepatocellular carcinoma and its association with immune cells using systemic inflammatory response index.
Zhao M; Duan X; Mi L; Shi J; Li N; Yin X; Han X; Wang J; Han G; Hou J; Yin F
Future Oncol; 2022 Jun; 18(18):2269-2288. PubMed ID: 35440159
[TBL] [Abstract][Full Text] [Related]
3. The Association of the Neutrophil-to-Lymphocyte Ratio, Platelet-to-Lymphocyte Ratio, Lymphocyte-to-Monocyte Ratio and Systemic Inflammation Response Index with Short-Term Functional Outcome in Patients with Acute Ischemic Stroke.
Zhang YX; Shen ZY; Jia YC; Guo X; Guo XS; Xing Y; Tian SJ
J Inflamm Res; 2023; 16():3619-3630. PubMed ID: 37641703
[TBL] [Abstract][Full Text] [Related]
4. The Pretreatment Systemic Inflammation Response Index as a Useful Prognostic Factor is Better Than Lymphocyte to Monocyte Ratio in Breast Cancer Patients Receiving Neoadjuvant Chemotherapy.
Jiang C; Zhang S; Qiao K; Xiu Y; Yu X; Huang Y
Clin Breast Cancer; 2022 Jul; 22(5):424-438. PubMed ID: 35428593
[TBL] [Abstract][Full Text] [Related]
5. Clinicopathological Aspects and Inflammation-Immune Markers in Alcohol and/or Hepatitis C Virus-Induced Hepatocellular Carcinoma Patients Treated With Sorafenib.
Pinto TAM; Saito HPA; Nourani CL; Ataide EC; Boin IFSF; Lourenco GJ; Lima CSP
Gastroenterology Res; 2024 Feb; 17(1):23-31. PubMed ID: 38463146
[TBL] [Abstract][Full Text] [Related]
6. Predictive value of preoperative inflammatory indexes for postoperative early recurrence of hepatitis B-related hepatocellular carcinoma.
Wenpei G; Yuan L; Liangbo L; Jingjun M; Bo W; Zhiqiang N; Yijie N; Lixin L
Front Oncol; 2023; 13():1142168. PubMed ID: 37519805
[TBL] [Abstract][Full Text] [Related]
7. Systemic inflammation response index (SIRI) as a predictive factor for overall survival in advanced soft tissue sarcoma treated with eribulin.
Kobayashi H; Okuma T; Okajima K; Ishibashi Y; Zhang L; Hirai T; Ohki T; Ikegami M; Sawada R; Shinoda Y; Akiyama T; Goto T; Tanaka S
J Orthop Sci; 2022 Jan; 27(1):222-228. PubMed ID: 33384219
[TBL] [Abstract][Full Text] [Related]
8. Predictive Value of Pretreatment Lymphocyte-to-Monocyte Ratio and Platelet-to-Lymphocyte Ratio in the Survival of Nasopharyngeal Carcinoma Patients.
Chen Y; Sun J; Hu D; Zhang J; Xu Y; Feng H; Chen Z; Luo Y; Lou Y; Wu H
Cancer Manag Res; 2021; 13():8767-8779. PubMed ID: 34866938
[TBL] [Abstract][Full Text] [Related]
9. Inflammation markers and the risk of hypertension in people living with HIV.
Ou-Yang H; Fu HY; Luo Y; Xu ZY; Liu J; Gao R; Duan JY; Mao YC; Li HJ; Du YR
Front Immunol; 2023; 14():1133640. PubMed ID: 37025998
[TBL] [Abstract][Full Text] [Related]
10. The Predictive Role of Systemic Inflammation Response Index (SIRI) in the Prognosis of Stroke Patients.
Zhang Y; Xing Z; Zhou K; Jiang S
Clin Interv Aging; 2021; 16():1997-2007. PubMed ID: 34880606
[TBL] [Abstract][Full Text] [Related]
11. Combination of psoas muscle mass index and neutrophil/lymphocyte ratio as a prognostic predictor for patients undergoing nonsurgical hepatocellular carcinoma therapy.
Sugama Y; Miyanishi K; Osuga T; Tanaka S; Hamaguchi K; Ito R; Sakamoto H; Kubo T; Ohnuma H; Murase K; Takada K; Kobune M; Kato J
JGH Open; 2021 Dec; 5(12):1335-1343. PubMed ID: 34950776
[TBL] [Abstract][Full Text] [Related]
12. Prognostic significance of psoas muscle index in male hepatocellular carcinoma patients treated with immune checkpoint inhibitors and tyrosine kinase inhibitors.
Luo N; Li H; Luo Y; Hu P; Liang L; Zhang R; Zhang D; Cai D; Kang J
Hum Vaccin Immunother; 2023 Aug; 19(2):2258567. PubMed ID: 37728115
[TBL] [Abstract][Full Text] [Related]
13. In Gastric Cancer Patients Receiving Neoadjuvant Chemotherapy Systemic Inflammation Response Index is a Useful Prognostic Indicator.
Chen L; Chen Y; Zhang L; Xue Y; Zhang S; Li X; Song H
Pathol Oncol Res; 2021; 27():1609811. PubMed ID: 34712105
[No Abstract] [Full Text] [Related]
14. Prognostic Value of Inflammatory Markers in Nasopharyngeal Carcinoma Patients in the Intensity-Modulated Radiotherapy Era.
Li Q; Yu L; Yang P; Hu Q
Cancer Manag Res; 2021; 13():6799-6810. PubMed ID: 34512020
[TBL] [Abstract][Full Text] [Related]
15. Low Psoas-Muscle index is associated with decreased survival in hepatocellular carcinoma treated with transarterial chemoembolization.
Zhang JX; Yan HT; Ding Y; Liu J; Liu S; Zu QQ; Shi HB
Ann Med; 2022 Dec; 54(1):1562-1569. PubMed ID: 35639492
[TBL] [Abstract][Full Text] [Related]
16. Systemic Inflammation Response Index is a Prognostic Risk Factor in Patients with Hepatocellular Carcinoma Undergoing TACE.
Wang TC; An TZ; Li JX; Pang PF
Risk Manag Healthc Policy; 2021; 14():2589-2600. PubMed ID: 34188570
[TBL] [Abstract][Full Text] [Related]
17. Clinical Impact of Sarcopenia and Inflammatory/Nutritional Markers in Patients with Unresectable Metastatic Urothelial Carcinoma Treated with Pembrolizumab.
Shimizu T; Miyake M; Hori S; Ichikawa K; Omori C; Iemura Y; Owari T; Itami Y; Nakai Y; Anai S; Tomioka A; Tanaka N; Fujimoto K
Diagnostics (Basel); 2020 May; 10(5):. PubMed ID: 32429323
[TBL] [Abstract][Full Text] [Related]
18. Pretreatment systemic inflammation response index is predictive of pathological complete response in patients with breast cancer receiving neoadjuvant chemotherapy.
Dong J; Sun Q; Pan Y; Lu N; Han X; Zhou Q
BMC Cancer; 2021 Jun; 21(1):700. PubMed ID: 34126950
[TBL] [Abstract][Full Text] [Related]
19. Osteosarcopenic obesity and its components-osteoporosis, sarcopenia, and obesity-are associated with blood cell count-derived inflammation indices in older Chinese people.
Nie YZ; Yan ZQ; Yin H; Shan LH; Wang JH; Wu QH
BMC Geriatr; 2022 Jun; 22(1):532. PubMed ID: 35764967
[TBL] [Abstract][Full Text] [Related]
20. Systemic inflammatory response index and monocyte-to-high density lipoprotein ratio- new biomarkers remarking the inflammation in primary sarcopenia: The SIMPS study.
Bektan Kanat B; Suzan V; Ulugerger Avci G; Unal D; Emiroglu Gedik T; Suna Erdincler D; Doventas A; Yavuzer H
Bratisl Lek Listy; 2024; 125(5):331-336. PubMed ID: 38624059
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
